Alternative splicing for diseases, cancers, drugs, and databases

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Tang, Jen Yang ^a,b   Lee, Jin Ching ^c   Hou, Ming Feng ^b,c,d   Wang, Chun Lin ^e   Chen, Chien Chi ^e   Huang, Hurng Wern ^f   Chang, Hsueh Wei ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^e FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^f NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; ACLARUBICIN; ANTINEOPLASTIC AGENT; APC PROTEIN; CARDIOVASCULAR AGENT; CYCLIN D1; DICHLOROINDOLYL ENAMINONITRILE; ESTROGEN RECEPTOR ALPHA 36; FR 901464; HYDROXYUREA; INDOPROFEN; KRUPPEL LIKE FACTOR 6; MEAYAMYCIN; MESSENGER RNA; MITOXANTRONE; PHORBOL 13 ACETATE 12 MYRISTATE; PLADIENOLIDE B; SPLICEOSTATIN A; SUDEMYCIN DERIVATIVE; SURVIVAL MOTOR NEURON PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; VALPROIC ACID; VANADATE SODIUM; XENOBIOTIC AGENT;

ALTERNATIVE RNA SPLICING; ANTINEOPLASTIC ACTIVITY; BIOINFORMATICS; BREAST CANCER; CARDIOMYOPATHY; COLON CANCER; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG POTENTIATION; DRUG SYNTHESIS; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FAMILIAL DISEASE; GENETIC ASSOCIATION; GENETIC DATABASE; HUMAN; LIVER CANCER; LUNG CANCER; MELANOMA; NEOPLASM; NONHUMAN; OVARY CANCER; PROSTATE CANCER; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL MUSCULAR ATROPHY; SPLICEOSOME; ANIMAL; GENE THERAPY; GENETICS;

ALTERNATIVE SPLICING; ANIMALS; ANTINEOPLASTIC AGENTS; DATABASES, GENETIC; GENETIC THERAPY; HUMANS; NEOPLASMS;

EID: 84878636369     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/703568     Document Type: Review

References (132)

1. Brett D., Pospisil H., Valcárcel J., Reich J., Bork P., Alternative splicing and genome complexity. Nature Genetics 2002 30 1 29 30 2-s2.0-0036338127 10.1038/ng803
2. Ghigna C., De Toledo M., Bonomi S., Valacca C., Gallo S., Apicella M., Eperon I., Tazi J., Biamonti G., Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives. RNA Biology 2010 7 4 495 503 2-s2.0-77957302252 10.4161/rna.7.4.12744
3. Mittendorf K. F., Deatherage C. L., Ohi M. D., Sanders C. R., Tailoring of membrane proteins by alternative splicing of pre-mRNA. Biochemistry 2012 51 28 5541 5556 10.1021/bi3007065
4. Luco R. F., Allo M., Schor I. E., Kornblihtt A. R., Misteli T., Epigenetics in alternative pre-mRNA splicing. Cell 2011 144 1 16 26 2-s2.0-78650961149 10.1016/j.cell.2010.11.056
5. Poulos M. G., Batra R., Charizanis K., Swanson M. S., Developments in RNA splicing and disease. Cold Spring Harbor Perspectives in Biology 2011 3 1 a000778 2-s2.0-79960627395 10.1101/cshperspect.a000778
6. Mills J. D., Janitz M., Alternative splicing of mRNA in the molecular pathology of neurodegenerative diseases. Neurobiology of Aging 2012 33 5 1011 1024
7. Yap K., Makeyev E. V., Regulation of gene expression in mammalian nervous system through alternative pre-mRNA splicing coupled with RNA quality control mechanisms. Molecular and Cellular Neuroscience 2013 10.1016/j.mcn.2013.01.003
8. Fu R. H., Liu S. P., Huang S. J., Chen H. J., Chen P. R., Lin Y. H., Ho Y. C., Chang W. L., Tsai C. H., Shyu W. C., Lin S. Z., Aberrant alternative splicing events in Parkinson's disease. Cell Transplantation 2013 22 4 653 661 10.3727/096368912X655154
9. Pearn J., Classification of spinal muscular atrophies. Lancet 1980 1 8174 919 922 2-s2.0-0018906764 (Pubitemid 10144202)
10. Zhou J., Zheng X., Shen H., Targeting RNA-splicing for SMA treatment. Molecules and Cells 2012 33 3 223 228 10.1007/s10059-012-0005-6
11. 2+- ATPase1 (SERCA1) by phorbol 12-myristate 13-acetate (PMA) via a PKC pathway. Biochemical and Biophysical Research Communications 2012 423 2 212 217 10.1016/j.bbrc.2012.05. 033
12. Cooper T. A., Alternative splicing regulation impacts heart development. Cell 2005 120 1 1 2 2-s2.0-11844281510 10.1016/j.cell.2004.12.030 (Pubitemid 40094593)
13. Lara-Pezzi E., Dopazo A., Manzanares M., Understanding cardiovascular disease: a journey through the genome (and what we found there). Disease Models & Mechanisms 2012 5 4 434 443 10.1242/dmm.009787
14. Bogdanov V. Y., Blood coagulation and alternative pre-mRNA splicing: an overview. Current Molecular Medicine 2006 6 8 859 869 2-s2.0-33845361026 10.2174/156652406779010821 (Pubitemid 44883937)
15. Medina M. W., Krauss R. M., Alternative splicing in the regulation of cholesterol homeostasis. Current Opinion in Lipidology 2013 24 2 147 152 10.1097/MOL.0b013e32835cf284
16. Endo-Umeda K., Uno S., Fujimori K., Naito Y., Saito K., Yamagishi K., Jeong Y., Miyachi H., Tokiwa H., Yamada S., Makishima M., Differential expression and function of alternative splicing variants of human liver X receptor alpha. Molecular Pharmacology 2012 81 6 800 810 10.1124/mol.111.077206
17. Manetti M., Guiducci S., Ibba-Manneschi L., Matucci-Cerinic M., Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant. Trends in Cardiovascular Medicine 2011 21 7 204 210 10.1016/j.tcm.2012.05.011
18. Xu X., Yang D., Ding J. H., Wang W., Chu P. H., Dalton N. D., Wang H. Y., Bermingham J. R., Ye Z., Liu F., Rosenfeld M. G., Manley J. L., Ross J., Chen J., Xiao R. P., Cheng H., Fu X. D., ASF/SF2-regulated CaMKII δ alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 2005 120 1 59 72 2-s2.0-19944427655 10.1016/j.cell.2004.11.036 (Pubitemid 40094603)
19. Fedorov O., Huber K., Eisenreich A., Filippakopoulos P., King O., Bullock A. N., Szklarczyk D., Jensen L. J., Fabbro D., Trappe J., Rauch U., Bracher F., Knapp S., Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chemistry & Biology 2011 18 1 67 76 10.1016/j.chembiol.2010.11.009
20. Kong S. W., Hu Y. W., Ho J. W. K., Ikeda S., Polster S., John R., Hall J. L., Bisping E., Pieske B., Dos Remedios C. G., Pu W. T., Heart failure-associated changes in RNA splicing of sarcomere genes. Circulation 2010 3 2 138 146 2-s2.0-77953677503 10.1161/CIRCGENETICS.109.904698
21. Burkhardt R., Kenny E. E., Lowe J. K., Birkeland A., Josowitz R., Noel M., Salit J., Maller J. B., Pe'er I., Daly M. J., Altshuler D., Stoffel M., Friedman J. M., Breslow J. L., Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 11 2078 2084 2-s2.0-55449105227 10.1161/ATVBAHA.108.172288
22. Zhu H., Tucker H. M., Grear K. E., Simpson J. F., Manning A. K., Cupples L. A., Estus S., A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. Human Molecular Genetics 2007 16 14 1765 1772 2-s2.0-34547793131 10.1093/hmg/ddm124 (Pubitemid 47241835)
23. Schmidt R. J., Zhang Y., Zhao Y., Qian Y. W., Wang H., Lin A., Ehsani M. E., Yu X., Wang G., Singh J., Su E. W., Li S., Konrad R. J., Cao G., A novel splicing variant of proprotein convertase subtilisin/kexin type 9. DNA and Cell Biology 2008 27 4 183 189 2-s2.0-42149196014 10.1089/dna.2007.0667 (Pubitemid 351535853)
24. Gil G., Smith J. R., Goldstein J. L., Brown M. S., Optional exon in the 5′-untranslated region of 3-hydroxy-3-methylglutaryl coenzyme A synthase gene: conserved sequence and splicing pattern in humans and hamsters. Proceedings of the National Academy of Sciences of the United States of America 1987 84 7 1863 1866 2-s2.0-0023136487 (Pubitemid 17054113)
25. Houten S. M., Koster J., Romeijn G. J., Frenkel J., Di Rocco M., Caruso U., Landrieu P., Kelley R. I., Kuis W., Poll-The B. T., Gibson K. M., Wanders R. J. A., Waterham H. R., Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome. European Journal of Human Genetics 2001 9 4 253 259 2-s2.0-0035063676 10.1038/sj.ejhg.5200595 (Pubitemid 32366692)
26. Kaida D., Schneider-Poetsch T., Yoshida M., Splicing in oncogenesis and tumor suppression. Cancer Science 2012 103 9 1611 1616 10.1111/j.1349-7006.2012. 02356.x
27. Hagen R. M., Ladomery M. R., Role of splice variants in the metastatic progression of prostate cancer. Biochemical Society Transactions 2012 40 4 870 874 10.1042/BST20120026
28. Sampath J., Pelus L. M., Alternative splice variants of survivin as potential targets in cancer. Current Drug Discovery Technologies 2007 4 3 174 191 2-s2.0-36448944759 10.2174/157016307782109652 (Pubitemid 350171819)
29. Miura K., Fujibuchi W., Sasaki I., Alternative pre-mRNA splicing in digestive tract malignancy. Cancer Science 2011 102 2 309 316 2-s2.0-79952081852 10.1111/j.1349-7006.2010.01797.x
30. Okumura N., Yoshida H., Kitagishi Y., Nishimura Y., Matsuda S., Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer. Biochemical and Biophysical Research Communications 2011 413 3 395 399 10.1016/j.bbrc.2011.08.098
31. Talieri M., Devetzi M., Scorilas A., Pappa E., Tsapralis N., Missitzis I., Ardavanis A., Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact. Tumor Biology 2012 33 4 1075 1084 10.1007/s13277-012-0347-x
32. Tammaro C., Raponi M., Wilson D. I., Baralle D., BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer. Biochemical Society Transactions 2012 40 4 768 772 10.1042/BST20120140
33. Zhong J., Cao R. X., Zu X. Y., Hong T., Yang J., Liu L., Xiao X. H., Ding W. J., Zhao Q., Liu J. H., Wen G. B., Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma. FEBS Journal 2012 279 2 316 335 10.1111/j.1742-4658.2011.08426.x
34. Albert H., Santos S., Battaglia E., Brito M., Monteiro C., Bagrel D., Differential expression of CDC25 phosphatases splice variants in human breast cancer cells. Clinical Chemistry and Laboratory Medicine 2011 49 10 1707 1714
35. Sebban S., Golan-Gerstl R., Karni R., Vaksman O., Davidson B., Reich R., Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer. Clinical and Experimental Metastasis 2013 30 1 103 117 10.1007/s10585-012-9514-0
36. Wang Y., Chan D. W., Liu V. W. S., Chiu P. M., Ngan H. Y. S., Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis. Clinical Cancer Research 2010 16 9 2529 2539 2-s2.0-77951758017 10.1158/1078-0432.CCR-10-0018
37. Haile S., Sadar M. D., Androgen receptor and its splice variants in prostate cancer. Cellular and Molecular Life Sciences 2011 68 24 3971 3981 10.1007/s00018-011-0766-7
38. Usher P. A., Sieuwerts A. M., Bartels A., Lademann U., Nielsen H. J., Holten-Andersen L., Foekens J. A., Brünner N., Offenberg H., Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue. Molecular Oncology 2007 1 2 205 215 2-s2.0-34547573074 10.1016/j.molonc.2007.05.002 (Pubitemid 47199133)
39. Gotley D. C., Fawcett J., Walsh M. D., Reeder J. A., Simmons D. L., Antalis T. M., Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. British Journal of Cancer 1996 74 3 342 351 2-s2.0-0030055727 (Pubitemid 26254561)
40. Pio R., Montuenga L. M., Alternative splicing in lung cancer. Journal of Thoracic Oncology 2009 4 6 674 678 2-s2.0-67849087126 10.1097/JTO. 0b013e3181a520dc
41. Moretti D., Del Bello B., Cosci E., Biagioli M., Miracco C., Maellaro E., Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions. Carcinogenesis 2009 30 6 960 967 2-s2.0-66749173427 10.1093/carcin/bgp098
42. Hanoun N., Bureau C., Diab T., Gayet O., Dusetti N., Selves J., Vinel J. P., Buscail L., Cordelier P., Torrisani J., The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions. Journal of Hepatology 2010 53 5 880 888 2-s2.0-77957326321 10.1016/j.jhep.2010.04.038
43. Yi Q., Tang L., Alternative spliced variants as biomarkers of colorectal cancer. Current Drug Metabolism 2011 12 10 966 974 10.2174/138920011798062355
44. Omenn G. S., Yocum A. K., Menon R., Alternative splice variants, a new class of protein cancer biomarker candidates: findings in pancreatic cancer and breast cancer with systems biology implications. Disease Markers 2010 28 4 241 251 2-s2.0-77954131742 10.3233/DMA-2010-0702
45. Lee Y., Gamazon E. R., Rebman E., Lee Y., Lee S., Dolan M. E., Cox N. J., Lussier Y. A., Variants affecting exon skipping contribute to complex traits. PLOS Genetics 2012 8 10 e1002998
46. Feng H., Qin Z., Zhang X., Opportunities and methods for studying alternative splicing in cancer with RNA-Seq. Cancer Letters 2012 10.1016/j.canlet.2012.11.010
47. Li G., Bahn J. H., Lee J. H., Peng G., Chen Z., Nelson S. F., Xiao X., Identification of allele-specific alternative mRNA processing via transcriptome sequencing. Nucleic Acids Research 2012 40 13, article e104
48. Xi L., Feber A., Gupta V., Wu M., Bergemann A. D., Landreneau R. J., Litle V. R., Pennathur A., Luketich J. D., Godfrey T. E., Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Research 2008 36 20 6535 6547 2-s2.0-56649083778 10.1093/nar/gkn697
49. Ben-Dov C., Hartmann B., Lundgren J., Valcárcel J., Genome-wide analysis of alternative pre-mRNA splicing. Journal of Biological Chemistry 2008 283 3 1229 1233 2-s2.0-38349132539 10.1074/jbc.R700033200
50. Gautschi O., Ratschiller D., Gugger M., Betticher D. C., Heighway J., Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 2007 55 1 1 14 2-s2.0-33845951110 10.1016/j.lungcan.2006.09.024 (Pubitemid 46038884)
51. Lamolle G., Marin M., Alvarez-Valin F., Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers. Mutation Research 2006 600 1-2 102 112 2-s2.0-33747482692 10.1016/j.mrfmmm.2006.03.004 (Pubitemid 44255828)
52. Neklason D. W., Solomon C. H., Dalton A. L., Kuwada S. K., Burt R. W., Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype. Familial Cancer 2004 3 1 35 40 2-s2.0-3142698784 10.1023/B:FAME. 0000026824.85766.22 (Pubitemid 40655352)
53. Raponi M., Kralovicova J., Copson E., Divina P., Eccles D., Johnson P., Baralle D., Vorechovsky I., Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6. Human Mutation 2011 32 4 436 444 2-s2.0-79952755720 10.1002/humu.21458
54. Liu H. X., Cartegni L., Zhang M. Q., Krainer A. R., A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nature Genetics 2001 27 1 55 58 2-s2.0-0035158730 10.1038/83762 (Pubitemid 32044518)
55. Narla G., DiFeo A., Reeves H. L., Schaid D. J., Hirshfeld J., Hod E., Katz A., Isaacs W. B., Hebbring S., Komiya A., McDonnell S. K., Wiley K. E., Jacobsen S. J., Isaacs S. D., Walsh P. C., Zheng S. L., Chang B. L., Friedrichsen D. M., Stanford J. L., Ostrander E. A., Chinnaiyan A. M., Rubin M. A., Xu J., Thibodeau S. N., Friedman S. L., Martignetti J. A., A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Research 2005 65 4 1213 1222 2-s2.0-13944252065 10.1158/0008-5472.CAN-04-4249 (Pubitemid 40270146)
56. Narla G., Difeo A., Yao S., Banno A., Hod E., Reeves H. L., Qiao R. F., Camacho-Vanegas O., Levine A., Kirschenbaum A., Chan A. M., Friedman S. L., Martignetti J. A., Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Research 2005 65 13 5761 5768 2-s2.0-21344473196 10.1158/0008-5472.CAN-05-0217 (Pubitemid 40911179)
57. DiFeo A., Feld L., Rodriguez E., Wang C., Beer D. G., Martignetti J. A., Narla G., A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. Cancer Research 2008 68 4 965 970 2-s2.0-39449090999 10.1158/0008-5472.CAN-07-2604 (Pubitemid 351272212)
58. Yang J. O., Kim W. Y., Bhak J., ssSNPTarget: genome-wide splice-site single nucleotide polymorphism database. Human Mutation 2009 30 12 E1010 E1020 2-s2.0-71749092105 10.1002/humu.21128
59. Douglas A. G., Wood M. J., RNA splicing: disease and therapy. Briefings in Functional Genomics 2011 10 3 151 164 10.1093/bfgp/elr020
60. Singh R. K., Cooper T. A., Pre-mRNA splicing in disease and therapeutics. Trends in Molecular Medicine 2012 18 8 472 482 10.1016/j.molmed.2012.06.006
61. Spitali P., Aartsma-Rus A., Splice modulating therapies for human disease. Cell 2012 148 6 1085 1088 10.1016/j.cell.2012.02.014
62. Miura K., Fujibuchi W., Unno M., Splice isoforms as therapeutic targets for colorectal cancer. Carcinogenesis 2012 33 12 2311 2319 10.1093/carcin/bgs347
63. Maciejewski J. P., Padgett R. A., Defects in spliceosomal machinery: a new pathway of leukaemogenesis. British Journal of Haematology 2012 158 2 165 173 10.1111/j.1365-2141.2012.09158.x
64. Hagiwara M., Alternative splicing: a new drug target of the post-genome era. Biochimica et Biophysica Acta 2005 1754 1-2 324 331 2-s2.0-29144463738 10.1016/j.bbapap.2005.09.010 (Pubitemid 41797714)
65. Blair C. A., Zi X., Potential molecular targeting of splice variants for cancer treatment. Indian Journal of Experimental Biology 2011 49 11 836 839
66. Van Alphen R. J., Wiemer E. A. C., Burger H., Eskens F. A. L. M., The spliceosome as target for anticancer treatment. British Journal of Cancer 2009 100 2 228 232 2-s2.0-58749105294 10.1038/sj.bjc.6604801
67. Bonnal S., Vigevani L., Valcarcel J., The spliceosome as a target of novel antitumour drugs. Nature Reviews Drug Discovery 2012 11 11 847 859 10.1038/nrd3823
68. Barrie E. S., Smith R. M., Sanford J. C., Sadee W., mRNA transcript diversity creates new opportunities for pharmacological intervention. Molecular Pharmacology 2012 81 5 620 630 10.1124/mol.111.076604
69. Zhang M. L., Lorson C. L., Androphy E. J., Zhou J., An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Therapy 2001 8 20 1532 1538 2-s2.0-0035158371 10.1038/sj.gt.3301550 (Pubitemid 33061891)
70. Andreassi C., Jarecki J., Zhou J., Coovert D. D., Monani U. R., Chen X., Whitney M., Pollok B., Zhang M., Androphy E., Burghes A. H. M., Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Human Molecular Genetics 2001 10 24 2841 2849 2-s2.0-0035891862 (Pubitemid 34026465)
71. Lunn M. R., Root D. E., Martino A. M., Flaherty S. P., Kelley B. P., Coovert D. D., Burghes A. H., Thi Man N., Morris G. E., Zhou J., Androphy E. J., Sumner C. J., Stockwell B. R., Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chemistry and Biology 2004 11 11 1489 1493 2-s2.0-8844240017 10.1016/j.chembiol.2004.08.024 (Pubitemid 39527275)
72. Xu C., Chen X., Grzeschik S. M., Ganta M., Wang C. H., Hydroxyurea enhances SMN2 gene expression through nitric oxide release. Neurogenetics 2011 12 1 19 24 2-s2.0-79951549405 10.1007/s10048-010-0268-z
73. Weihl C. C., Connolly A. M., Pestronk A., Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy. Neurology 2006 67 3 500 501 2-s2.0-33747083488 10.1212/01.wnl.0000231139.26253.d0 (Pubitemid 44214981)
74. Yuo C. Y., Lin H. H., Chang Y. S., Yang W. K., Chang J. G., 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells. Annals of Neurology 2008 63 1 26 34 2-s2.0-39049125699 10.1002/ana.21241 (Pubitemid 351240548)
75. Andreassi C., Angelozzi C., Tiziano F. D., Vitali T., De Vincenzi E., Boninsegna A., Villanova M., Bertini E., Pini A., Neri G., Brahe C., Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. European Journal of Human Genetics 2004 12 1 59 65 2-s2.0-10744229981 10.1038/sj.ejhg.5201102 (Pubitemid 38180971)
76. Zhang Z., Kelemen O., Van Santen M. A., Yelton S. M., Wendlandt A. E., Sviripa V. M., Bollen M., Beullens M., Urlaub H., Lührmann R., Watt D. S., Stamm S., Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNA. Journal of Biological Chemistry 2011 286 12 10126 10136 2-s2.0-79953169568 10.1074/jbc.M110.183970
77. Harahap I. S. K., Saito T., San L. P., Sasaki N., Gunadi, Nurputra D. K. P., Yusoff S., Yamamoto T., Morikawa S., Nishimura N., Lee M. J., Takeshima Y., Matsuo M., Nishio H., Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines. Brain and Development 2011 2-s2.0-79955692915 10.1016/j.braindev.2011.04.010
78. Zheng S., Chen Y., Donahue C. P., Wolfe M. S., Varani G., Structural Basis for Stabilization of the Tau Pre-mRNA Splicing Regulatory Element by Novantrone (Mitoxantrone). Chemistry and Biology 2009 16 5 557 566 2-s2.0-65749105061 10.1016/j.chembiol.2009.03.009
79. Lewis J. S., Jordan V. C., Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Mutation Research 2005 591 1-2 247 263 2-s2.0-27844511538 10.1016/j.mrfmmm.2005.02.028 (Pubitemid 41654853)
80. Lin S. L., Yan L. Y., Zhang X. T., Yuan J., Li M., Qiao J., Wang Z. Y., Sun Q. Y., ER- α 36, a variant of ER- α promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways. PLoS ONE 2010 5 2 2-s2.0-77749252827 10.1371/journal.pone.0009013 e9013
81. Zaharieva E., Chipman J. K., Soller M., Alternative splicing interference by xenobiotics. Toxicology 2012 296 1 12 10.1016/j.tox.2012.01.014
82. Kaida D., Motoyoshi H., Tashiro E., Nojima T., Hagiwara M., Ishigami K., Watanabe H., Kitahara T., Yoshida T., Nakajima H., Tani T., Horinouchi S., Yoshida M., Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nature Chemical Biology 2007 3 9 576 583 2-s2.0-34548095157 10.1038/nchembio.2007.18 (Pubitemid 47294395)
83. Kotake Y., Sagane K., Owa T., Mimori-Kiyosue Y., Shimizu H., Uesugi M., Ishihama Y., Iwata M., Mizui Y., Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nature Chemical Biology 2007 3 9 570 575 2-s2.0-34548104659 10.1038/nchembio.2007.16 (Pubitemid 47294394)
84. Fan L., Lagisetti C., Edwards C. C., Webb T. R., Potter P. M., Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing. ACS Chemical Biology 2011 6 6 582 589 2-s2.0-79961049732 10.1021/cb100356k
85. Corrionero A., Miñana B., Valcárcel J., Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. Genes and Development 2011 25 5 445 459 2-s2.0-79952220808 10.1101/gad.2014311
86. Furumai R., Uchida K., Komi Y., Yoneyama M., Ishigami K., Watanabe H., Kojima S., Yoshida M., Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF. Cancer Science 2010 101 11 2483 2489 2-s2.0-78049422746 10.1111/j.1349-7006.2010.01686.x
87. Nakajima H., Sato B., Fujita T., Takase S., Terano H., Okuhara M., New antitumor substances, FR901463, FR901464 and FR901465: I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. Journal of Antibiotics 1996 49 12 1196 1203 2-s2.0-0030461311
88. Albert B. J., McPherson P. A., O'Brien K., Czaicki N. L., DeStefino V., Osman S., Li M., Day B. W., Grabowski P. J., Moore M. J., Vogt A., Koide K., Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells. Molecular Cancer Therapeutics 2009 8 8 2308 2318 2-s2.0-68849084041 10.1158/1535-7163.MCT-09-0051
89. Woolard J., Vousden W., Moss S. J., Krishnakumar A., Gammons M. V., Nowak D. G., Dixon N., Micklefield J., Spannhoff A., Bedford M. T., Gregory M. A., Martin C. J., Leadlay P. F., Zhang M. Q., Harper S. J., Bates D. O., Wilkinson B., Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chemical Science 2011 2011 2 273 278
90. Shamim U., Hanif S., Albanyan A., Beck F. W., Bao B., Wang Z., Banerjee S., Sarkar F. H., Mohammad R. M., Hadi S. M., Azmi A. S., Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer. Journal of Cellular Physiology 2012 227 4 1493 1500 10.1002/jcp.22865
91. Jakubikova J., Cervi D., Ooi M., Kim K., Nahar S., Klippel S., Cholujova D., Leiba M., Daley J. F., Delmore J., Negri J., Blotta S., McMillin D. W., Hideshima T., Richardson P. G., Sedlak J., Anderson K. C., Mitsiades C. S., Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica 2011 96 8 1170 1179 10.3324/haematol.2010.029363
92. Markus M. A., Marques F. Z., Morris B. J., Resveratrol, by modulating RNA processing factor levels, can influence the alternative splicing of pre-mRNAs. PLoS One 2011 6 12 e28926
93. Miura K., Fujibuchi W., Unno M., Splice variants in apoptotic pathway. Experimental Oncology 2012 34 3 212 217
94. Schwerk C., Schulze-Osthoff K., Regulation of apoptosis by alternative pre-mRNA splicing. Molecular Cell 2005 19 1 1 13 2-s2.0-21244439380 10.1016/j.molcel.2005.05.026 (Pubitemid 40884653)
95. Shkreta L., Froehlich U., Paquet E. R., Toutant J., Elela S. A., Chabot B., Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes. Molecular Cancer Therapeutics 2008 7 6 1398 1409 2-s2.0-49849102216 10.1158/1535-7163.MCT-08-0192
96. Lee J., Zhou J., Zheng X., Cho S., Moon H., Loh T. J., Jo K., Shen H., Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA. Biochemical and Biophysical Research Communications 2012 420 2 467 472 10.1016/j.bbrc.2012.03.029
97. Revil T., Toutant J., Shkreta L., Garneau D., Cloutier P., Chabot B., Protein kinase C-dependent control of Bcl-x alternative splicing. Molecular and Cellular Biology 2007 27 24 8431 8441 2-s2.0-37149014737 10.1128/MCB.00565-07
98. Shultz J. C., Goehe R. W., Wijesinghe D. S., Murudkar C., Hawkins A. J., Shay J. W., Minna J. D., Chalfant C. E., Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a. Cancer Research 2010 70 22 9185 9196 2-s2.0-78549234102 10.1158/0008-5472.CAN-10-1545
99. Puppin C., Passon N., Franzoni A., Russo D., Damante G., Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. Oncology Reports 2011 25 2 393 397 2-s2.0-78651372726 10.3892/or.2010.1075
100. Wu S., Li C., Huang W., Li W., Li R. W., Alternative splicing regulated by butyrate in bovine epithelial cells. PLoS One 2012 7 6 e39182
101. Lee C., Wang Q., Bioinformatics analysis of alternative splicing. Briefings in Bioinformatics 2005 6 1 23 33 2-s2.0-17244377195 10.1093/bib/6.1.23 (Pubitemid 40528577)
102. Florea L. D., Bioinformatics of alternative splicing and its regulation. Briefings in Bioinformatics 2006 7 1 55 69 2-s2.0-33748770921 10.1093/bib/bbk005 (Pubitemid 44404324)
103. Kim N., Lee C., Bioinformatics detection of alternative splicing. Methods in Molecular Biology 2008 452 179 197 2-s2.0-46449127795 10.1007/978-1-60327- 159-2-9
104. Ji H., Zhou Q., Wen F., Xia H., Lu X., Li Y., AsMamDB: an alternative splice database of mammals. Nucleic Acids Research 2001 29 1 260 263 2-s2.0-0035175280 (Pubitemid 32054462)
105. Huang Y. H., Chen Y. T., Lai J. J., Yang S. T., Yang U. C., PALS db: putative alternative splicing database. Nucleic Acids Research 2002 30 1 186 190 2-s2.0-0036081021
106. Lee C., Atanelov L., Modrek B., Xing Y., ASAP: the alternative splicing annotation project. Nucleic Acids Research 2003 31 1 101 105 2-s2.0-0037246718 10.1093/nar/gkg029 (Pubitemid 36150344)
107. Pospisil H., Herrmann A., Bortfeldt R. H., Reich J. G., EASED: Extended Alternatively Spliced EST Database. Nucleic Acids Research 2004 32 D70 D74 2-s2.0-0347899426 (Pubitemid 38087920)
108. Hsu F. R., Chang H. Y., Lin Y. L., Tsai Y. T., Peng H. L., Chen Y. T., Cheng C. Y., Shih M. Y., Liu C. H., Chen C. F., AVATAR: a database for genome-wide alternative splicing event detection using large scale ESTs and mRNAs., Bioinformation 2005 1 1 16 18 10.6026/97320630001016
109. Zheng C. L., Kwon Y. S., Hai-Ri L. I., Zhang K., Coutinho-Mansfield G., Yang C., Murlidharan Nair T., Gribskov M., Xiang-Dong F. U., MAASE: an alternative splicing database designed for supporting splicing microarray applications. RNA 2005 11 12 1767 1776 2-s2.0-28344432224 10.1261/rna.2650905 (Pubitemid 41720026)
110. Zhang H., Hu J., Recce M., Tian B., PolyA-DB: a database for mammalian mRNA polyadenylation. Nucleic Acids Research 2005 33 D116 D120 2-s2.0-13444302775 10.1093/nar/gki055 (Pubitemid 40207842)
111. Le Texier V., Riethoven J. J., Kumanduri V., Gopalakrishnan C., Lopez F., Gautheret D., Thanaraj T. A., AltTrans: transcript pattern variants annotated for both alternative splicing and alternative polyadenylation. BMC Bioinformatics 2006 7 article 169 2-s2.0-33645808501 10.1186/1471-2105-7-169
112. Kostadinov R., Malhotra N., Viotti M., Shine R., D'Antonio L., Bagga P., GRSDB: a database of quadruplex forming G-rich sequences in alternatively processed mammalian pre-mRNA sequences. Nucleic Acids Research 2006 34 D119 124 2-s2.0-33644877945
113. Holste D., Huo G., Tung V., Burge C. B., HOLLYWOOD: a comparative relational database of alternative splicing. Nucleic Acids Research 2006 34 D56 62 2-s2.0-33644877169
114. Stamm S., Riethoven J. J., Le Texier V., Gopalakrishnan C., Kumanduri V., Tang Y., Barbosa-Morais N. L., Thanaraj T. A., ASD: a bioinformatics resource on alternative splicing. Nucleic Acids Research 2006 34 D46 55 2-s2.0-33644878582
115. Rambaldi D., Felice B., Praz V., Bucher P., Cittaro D., Guffanti A., Splicy: a web-based tool for the prediction of possible alternative splicing events from Affymetrix probeset data. BMC Bioinformatics 2007 8 1, article no. S17 2-s2.0-34248140047 10.1186/1471-2105-8-S1-S17 (Pubitemid 351859174)
116. Foissac S., Sammeth M., ASTALAVISTA: dynamic and flexible analysis of alternative splicing events in custom gene datasets. Nucleic Acids Research 2007 35 W297 299 2-s2.0-34547599504 10.1093/nar/gkm311
117. Lacroix Z., Legendre C., Raschid L., Snyder B., BIPASS: BioInformatics Pipeline Alternative Splicing Services. Nucleic Acids Research 2007 35 W292 296 2-s2.0-34547602471 10.1093/nar/gkm344
118. Lee Y., Lee Y., Kim B., Shin Y., Nam S., Kim P., Kim N., Chung W. H., Kim J., Lee S., ECgene: an alternative splicing database update. Nucleic Acids Research 2007 35 1 D99 D103 2-s2.0-33846039709 10.1093/nar/gkl992 (Pubitemid 46056178)
119. Bhasi A., Pandey R. V., Utharasamy S. P., Senapathy P., EuSplice: a unified resource for the analysis of splice signals and alternative splicing in eukaryotic genes. Bioinformatics 2007 23 14 1815 1823 2-s2.0-34547869583 10.1093/bioinformatics/btm084 (Pubitemid 47250315)
120. Ryan M. C., Zeeberg B. R., Caplen N. J., Cleland J. A., Kahn A. B., Liu H., Weinstein J. N., SpliceCenter: a suite of web-based bioinformatic applications for evaluating the impact of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based studies. BMC Bioinformatics 2008 9 article 313 2-s2.0-48549091806 10.1186/1471-2105-9-313
121. Castrignanò T., D'Antonio M., Anselmo A., Carrabino D., D'Onorio de Meo A., D'Erchia A. M., Licciulli F., Mangiulli M., Mignone F., Pavesi G., Picardi E., Riva A., Rizzi R., Bonizzoni P., Pesole G., ASPicDB: a database resource for alternative splicing analysis. Bioinformatics 2008 24 10 1300 1304 2-s2.0-43349089687 10.1093/bioinformatics/btn113 (Pubitemid 351659628)
122. Bechtel J. M., Rajesh P., Ilikchyan I., Deng Y., Mishra P. K., Wang Q., Wu X., Afonin K. A., Grose W. E., Wang Y., Khuder S., Fedorov A., The Alternative Splicing Mutation Database: a hub for investigations of alternative splicing using mutational evidence. BMC Research Notes 2008 1 article 3 2-s2.0-77949988909 10.1186/1756-0500-1-3
123. Birzele F., Küffner R., Meier F., Oefinger F., Potthast C., Zimmer R., ProSAS: a database for analyzing alternative splicing in the context of protein structures. Nucleic Acids Research 2008 36 1 D63 D68 2-s2.0-38549167437 10.1093/nar/gkm793 (Pubitemid 351149697)
124. Floris M., Orsini M., Thanaraj T. A., Splice-mediated variants of proteins (SpliVaP)-data and characterization of changes in signatures among protein isoforms due to alternative splicing. BMC Genomics 2008 9 article 453 2-s2.0-54949135764 10.1186/1471-2164-9-453
125. Bhasi A., Philip P., Sreedharan V. T., Senapathy P., AspAlt: a tool for inter-database, inter-genomic and user-specific comparative analysis of alternative transcription and alternative splicing in 46 eukaryotes. Genomics 2009 94 1 48 54 2-s2.0-67349209837 10.1016/j.ygeno.2009.02.006
126. Koscielny G., Texier V. L., Gopalakrishnan C., Kumanduri V., Riethoven J. J., Nardone F., Stanley E., Fallsehr C., Hofmann O., Kull M., Harrington E., Boué S., Eyras E., Plass M., Lopez F., Ritchie W., Moucadel V., Ara T., Pospisil H., Herrmann A., Reich J. G., Guigó R., Bork P., Doeberitz M. V. K., Vilo J., Hide W., Apweiler R., Thanaraj T. A., Gautheret D., ASTD: the Alternative Splicing and Transcript Diversity database. Genomics 2009 93 3 213 220 2-s2.0-60049093585 10.1016/j.ygeno.2008.11.003
127. Sinha R., Lenser T., Jahn N., Gausmann U., Friedel S., Szafranski K., Huse K., Rosenstiel P., Hampe J., Schuster S., Hiller M., Backofen R., Platzer M., TassDB2: a comprehensive database of subtle alternative splicing events. BMC Bioinformatics 2010 11 article 216 2-s2.0-77951594700 10.1186/1471-2105-11-216
128. Takeda J. I., Suzuki Y., Sakate R., Sato Y., Gojobori T., Imanishi T., Sugano S., H-DBAS: Human-transcriptome database for alternative splicing: update 2010. Nucleic Acids Research 2009 38 1 D86 D90 2-s2.0-75549090156 10.1093/nar/gkp984 gkp984
129. Kroll J. E., Galante P. A., Ohara D. T., Navarro F. C., Ohno-Machado L., de Souza S. J., SPLOOCE: a new portal for the analysis of human splicing variants. RNA Biology 2012 9 11 1339 1343
130. Rodriguez J. M., Maietta P., Ezkurdia I., Pietrelli A., Wesselink J. J., Lopez G., Valencia A., Tress M. L., APPRIS: annotation of principal and alternative splice isoforms. Nucleic Acids Research 2013 41 110 117 10.1093/nar/gks959
131. Piva F., Giulietti M., Burini A. B., Principato G., SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Human Mutation 2012 33 1 81 85 10.1002/humu.21609
132. Wingender E., Schoeps T., Donitz J., TFClass: an expandable hierarchical classification of human transcription factors. Nucleic Acids Research 2013 41 165 170 10.1093/nar/gks1123